Simplify Medical: Simplify Disc 1 and 2-Level Abstracts to be Presented in the Best Papers Section at the North American Spine Society Meeting (NASS) Annual Meeting

SUNNYVALE, Calif., Oct. 07, 2020 (GLOBE NEWSWIRE) -- Simplify Medical, a privately-held company focused on cervical spinal disc arthroplasty and developer of the Simplify® Cervical Artificial Disc, announced today the North American Spine Society (NASS) selected two abstracts on the Simplify Disc for the Best Papers Section. The papers are being presented on both the 1-level and 2-level study outcomes by the co-primary investigators of the clinical trials- Richard Guyer, MD and Domagoj Coric, MD.The Simplify Disc PMA for the 1-level indication was recently approved by the FDA, achieving the quickest approval for any spine PMA. Simplify Disc's overall success rate of 93.0% was superior to the ACDF control at 73.6%. The late-stage 2-level indication is not yet ...Full story available on Benzinga.com